MPXOF (MPX International) Net Current Asset Value: $-0.17 (As of Mar. 2022)


What is MPX International Net Current Asset Value?

MPX International MPXOF -99.00% Net Current Asset Value is $-0.17 as of Mar. 2022.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

MPX International's net current asset value per share for the quarter that ended in Mar. 2022 was $-0.17.

The historical rank and industry rank for MPX International's Net Current Asset Value or its related term are showing as below:

MPXOF's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.32
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

MPX International  (OTCPK:MPXOF) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


MPX International Net Current Asset Value Related Terms


MPX International Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for MPX International's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPX International Net Current Asset Value Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
Net Current Asset Value
-0.01 0.11 -0.06 -0.11

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.08 -0.11 -0.13 -0.17

MPXOF vs ZTS, CTLT, VTRS: Net Current Asset Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPX International Price-to-Net-Current-Asset-Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where MPX International's Price-to-Net-Current-Asset-Value falls into.



MPX International Net Current Asset Value Calculation

MPX International's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Sep. 2021 is calculated as

Net Current Asset Value Per Share(A: Sep. 2021 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(10.137-21.96-4.236-0)/143.861
=-0.11

MPX International's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2022 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2022 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(6.701-29.419-2.333-0)/144.323
=-0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of $-0.17 mean?
MPX International (MPXOF) has a Net Current Asset Value of $-0.17 as of Mar. 2022. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MPX International and its competitors.
Is MPX International's Net Current Asset Value too high?
MPX International's current Net Current Asset Value is $-0.17.
How does MPX International's Net Current Asset Value compare to ZTS and CTLT?
MPX International's Net Current Asset Value of $-0.17 can be compared against companies in the Drug Manufacturers industry. The industry median Net Current Asset Value is 5.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Drug Manufacturers company?
The median Net Current Asset Value among Drug Manufacturers companies is 5.32, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MPX International and its competitors. For the Drug Manufacturers industry, the median Net Current Asset Value is 5.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MPX International's current Net Current Asset Value is $-0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPX International stock overvalued right now?
MPX International (MPXOF) has a current Net Current Asset Value of $-0.17. The current Net Current Asset Value is $-0.17. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For MPX International (MPXOF), the current Net Current Asset Value is $-0.17 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPX International Business Description

Address 5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.